← Open Payments lookup

MARK BLOCKER: Open Payments

NPI 1104321397 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,821 in 110 payments from 16 companies in 2025. Trend: 2023 $2,024 · 2024 $2,241 · 2025 $1,821

Food & beverage: $1,821
CompanyPaymentsAmount
Collegium Pharmaceutical, Inc.16$240
Noven Therapeutics, LLC22$217
Supernus Pharmaceuticals, Inc.7$167
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$166
Vanda Pharmaceuticals Inc.9$151
ABBVIE INC.10$151
Tris Pharma Inc9$144
Corium, LLC5$102
Neurocrine BioSciences, Inc.4$100
Takeda Pharmaceuticals U.S.A., Inc.4$82

Products named: Jornay PM, Xelstrym, Qelbree, CAPLYTA, FANAPT, VRAYLAR, Dyanavel XR, REXULTI.

Industry payments across GA — which companies pay providers there.